ocular toxicity

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2017
02420132017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
S-1 is an anticancer agent that consists of tegafur, gimeracil, and oteracil potassium at a molar ratio of 1:0.4:1. S-1 is used… (More)
Is this relevant?
Review
2016
Review
2016
Many classes of anticancer therapy, including chemotherapeutic agents, hormonal and molecular targeted treatments, can produce… (More)
Is this relevant?
2016
2016
This study aims to contribute to fill a knowledge gap related with Hg effects in fish eyes. As a pioneering strategy, Hg… (More)
Is this relevant?
2016
2016
AUY922, a heat shock protein 90 inhibitor is associated with ocular adverse events (AEs). To provide a better understanding of… (More)
Is this relevant?
2016
2016
CONTEXT Ethambutol-induced retinal oxidative damage in patients with tuberculosis is still not being adequately treated. The… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2016
Review
2016
In vivo toxicity and absorption studies of topical ocular drugs are problematic, because these studies involve invasive tissue… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2015
2015
Gellan gum, kappa-carrageenan and alginates are natural polysaccharides able to interact with different cations that can be used… (More)
Is this relevant?
2014
2014
INTRODUCTION Many prescribed drugs can adversely affect the eye by causing damage to the function of visual pathways or toxicity… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2014
Review
2014
The treatment of advanced disease (stage IIIb and IV) of non-small cell lung cancer (NSCLC) is based on systemic treatment with… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2013
2013
This study was performed to assess the in vivo ocular toxicity of benzalkonium chloride (BAK) homologs compared with commercially… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?